Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® According to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07382778

Acronym

VICTORY

Enrollment

1538

Registered

2026-02-03

Start date

2022-10-19

Completion date

2025-06-13

Last updated

2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia

Keywords

hypercholesterolemia, Diabetes Mellitus, Low Density Lipoprotein Cholesterol, Lipid Profile, Observational Study

Brief summary

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® according to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

Detailed description

A Multi-center, Open-label, Observational Study

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men and women aged ≥19 years * Diagnosed with hypercholesterolemia * LDL-C level meets cardiovascular/cerebrovascular risk group classification * Willing to participate for 12 months * Provided written informed consent

Exclusion criteria

\- Contraindications to Livalozet®

Design outcomes

Primary

Measure	Time frame
Percent change from baseline in LDL-C level at Week 24	From enrollment to the end of treatment at 24 weeks

Countries

South Korea

Outcome results